These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4869717)

  • 21. [Indications for the conservative and surgical management of Parkinsonism].
    Metzel E
    Neurochirurgia (Stuttg); 1970 Sep; 13(5):169-73. PubMed ID: 4917950
    [No Abstract]   [Full Text] [Related]  

  • 22. Pyridoxine, DOPA, and Parkinsonism.
    Yahr MD; Duvoisin RC; Côté L; Cohen G
    Adv Biochem Psychopharmacol; 1972; 4():185-94. PubMed ID: 4555927
    [No Abstract]   [Full Text] [Related]  

  • 23. L-dopa in the treatment of Parkinsonism; a preliminary appraisal.
    Stellar S; Mandell S; Waltz JM; Cooper IS
    J Neurosurg; 1970 Mar; 32(3):275-80. PubMed ID: 5416909
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experiences with L-DOPA (Eldopal) treatment of 40 patients with Parkinson's disease].
    Postma JU; Stam FC; Meerlo HJ
    Ned Tijdschr Geneeskd; 1971 Apr; 115(16):701-7. PubMed ID: 5551426
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of parkinsonism with L-Dopa associated with decarboxylase inhibitors. II].
    Gauthier G; de Ajuriaguerra J; Simona B; Constantinidis J; Eisenring JJ; Krassoievitch M; Yanniotis G; Tissot R
    Rev Neurol (Paris); 1970 Nov; 123(5):297-319. PubMed ID: 5513630
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of parkinsonism with L-dopa].
    Court J; Kase JC; Palacios E; Mena I
    Rev Med Chil; 1971 Jun; 99(6):399-401. PubMed ID: 5561157
    [No Abstract]   [Full Text] [Related]  

  • 27. Oral L-dopa treatment of parkinsonism.
    Andén NE; Carlsson A; Kerstell J; Magnusson T; Olsson R; Roos BE; Steen B; Steg G; Svanborg A; Thieme G; Werdinius B
    Acta Med Scand; 1970 Apr; 187(4):247-55. PubMed ID: 4911257
    [No Abstract]   [Full Text] [Related]  

  • 28. L-dopa therapy in Parkinson's disease.
    Lipman IJ
    Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138
    [No Abstract]   [Full Text] [Related]  

  • 29. L-dopa for Parkinsonism.
    Drug Ther Bull; 1969 Jul; 7(15):59-60. PubMed ID: 5806494
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical experience with L-DOPA in the treatment of parkinsonism].
    Chiba T
    No To Shinkei; 1970 Dec; 22(12):1399-405. PubMed ID: 5536833
    [No Abstract]   [Full Text] [Related]  

  • 31. [1-dopa for parkinsonism].
    Flatberg P
    Tidsskr Nor Laegeforen; 1970 May; 90(10):1102-3. PubMed ID: 5450048
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment with L-dopa in Parkinsonian syndromes].
    De Renzi E; Pieczuro A
    Sist Nerv; 1970; 22(1):1-11. PubMed ID: 5502951
    [No Abstract]   [Full Text] [Related]  

  • 33. [L-Dopa therapy in Parkinson's disease. A double-blind study].
    Worm-Petersen J; Dupont E; Mikkelsen B
    Ugeskr Laeger; 1971 Nov; 133(47):2321-6. PubMed ID: 4944651
    [No Abstract]   [Full Text] [Related]  

  • 34. [Levodopa treatment in parkinsonism].
    Rinne UK; Sonninen V; Siirtola T
    Duodecim; 1971; 87(12):933-47. PubMed ID: 5088232
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of Parkinsonism with Laevo-dopa.
    Mawdsley C
    Br Med J; 1970 Feb; 1(5692):331-7. PubMed ID: 4906702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients.
    Goodwin FK; Murphy DL; Brodie HK; Bunney WE
    Biol Psychiatry; 1970 Oct; 2(4):341-66. PubMed ID: 4920729
    [No Abstract]   [Full Text] [Related]  

  • 37. [L-dopa and parkinsonism. A preliminary report].
    Pakkenberg H
    Ugeskr Laeger; 1969 May; 131(22):959-60. PubMed ID: 5793628
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of Parkinsonism with L-dopa--with special reference to clinical effects, side effects and urinary metabolites of catecholamines].
    Uono M; Tanabe H; Yano Y; Nakao K
    No To Shinkei; 1970 Sep; 22(9):1091-101. PubMed ID: 5536082
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical analyses of factors influencing L-dopa treatment of Parkinson's syndrome.
    Granerus AK; Steg G; Svanborg A
    Acta Med Scand; 1972; 192(1-2):1-11. PubMed ID: 4559530
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of Levo-Dopa in the treatment of Parkinsonism (188 cases)].
    Fasano VA; Urciuoli R; Broggi G; Lombard GF
    Minerva Neurochir; 1970; 14(2):245-9. PubMed ID: 5515308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.